
Gravog M 500mg/0.3mg Tablet SR
Marketer
Precise Lifescience
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Gravog M 500mg/0.3mg Tablet SR
Diabetic patients using Gravog M 500mg/0.3mg SR tablets, an anti-diabetic medication, should be aware that it's a dual-action formulation for managing type 2 diabetes in adults. This medication aids in regulating blood glucose. Always take Gravog M with food, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continued use, even with controlled blood sugar, is crucial. Discontinuing without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your doctor. Lifestyle choices are vital for diabetes control. Potential side effects include nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin rashes – these are generally transient. Persistent or concerning side effects require immediate medical attention. Your doctor can offer management strategies. Gravog M is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before starting this medication. Pregnant or lactating women must consult their physician. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to assess blood cell counts and liver function.
Primary Ingredients of Gravog M 500mg/0.3mg Tablet SR
No information provided. A rephrased version cannot be created.
Uses of Gravog M 500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Gravog M 500mg/0.3mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Gravog M 500mg/0.3mg sustained-release tablets with food.
Common Side effects of Gravog M 500mg/0.3mg Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Gravog M 500mg/0.3mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Gravog M 500mg/0.3mg Extended-Release Tablet with a meal.
How Gravog M 500mg/0.3mg Tablet SR works:
Extended-release Gravog M tablets (500mg/0.3mg) contain a dual-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gravog M 500mg/0.3mg SR tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Gravog M 500mg/0.3mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Gravog M 500mg/0.3mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Gravog M 500mg/0.3mg Tablet SR. Nevertheless, patients using this medication concurrently with other antidiabetic drugs like sulfonylureas, insulin, or repaglinide should be aware of the potential for low blood sugar.
KidneyCAUTION
Patients with kidney impairment should use Gravog M 500mg/0.3mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is recommended. Gravog M 500mg/0.3mg Tablet SR is contraindicated in those with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gravog M 500mg/0.3mg Tablet SR to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take Gravog M 500mg/0.3mg Tablet SR :
Should you forget a dose of Gravog M 500mg/0.3mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gravog M 500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
